Paracetamol removal in subsurface flow constructed wetlands

Journal of Hydrology

Volumn 404, Issue 3-4, 2011, Pages 130-135

  Ranieri, Ezio ^a   Verlicchi, Paola ^b   Young, Thomas M ^c  

^a POLITECNICO DI BARI   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Constructed wetlands; Hydraulics; Model; Paracetamol; Phragmites australis; Typha latifolia

Indexed keywords

CONSTRUCTED WETLANDS; FIRST-ORDER MODELS; HALF LIVES; HORIZONTAL SUBSURFACE FLOW CONSTRUCTED WETLANDS; HYDRAULIC LOADING RATES; HYDRAULIC RESIDENCE TIME; MACROPHYTES; PARACETAMOL; PHRAGMITES; PHRAGMITES AUSTRALIS; PILOT SCALE; PLUG FLOW; RESIDENCE TIME DISTRIBUTIONS; SUBSURFACE FLOW CONSTRUCTED WETLANDS; TYPHA LATIFOLIA; VOID VOLUME FRACTION;

HYDRAULICS; SURFACE TREATMENT; TURBINES; VOID FRACTION;

WETLANDS;

ASSESSMENT METHOD; CONSTRUCTED WETLAND; HYDRAULIC CONDUCTIVITY; MACROPHYTE; POLLUTANT REMOVAL; POROSITY; SUBSURFACE FLOW; VOLUME;

ITALY; LECCE; PUGLIA;

PHRAGMITES; PHRAGMITES AUSTRALIS; TYPHA; TYPHA LATIFOLIA;

EID: 79959230312     PISSN: 00221694     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhydrol.2011.03.015     Document Type: Article

References (35)

1. Agenzia Italiana del Farmaco, 2005. Bollettino di informazione. Ministero della Salute, Roma.
2. Bound J.P., Voulvoulis N. Pharmaceuticals in the aquatic environment--a comparison of risk assessment strategies. Chemosphere 2004, 56:1143-1155.
3. Chen G., Ye J., Bao H., Yang P. Determination of the rate constants and activation energy of acetaminophen hydrolysis by capillary electrophoresis. Journal of Pharmaceutical and Biomedical Analysis 2002, 29:843-850.
4. Grung M., Kallqvista T., Sakshaug S., Skurtveit S., Thomas K.V. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicology and Environmental Safety 2008, 71:328-340.
5. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. Journal of Hydrology 2002, 266:175-189.
6. Henschel K.P., Wenzel A., Diedrich M., Fliedner A. Environmental hazard assessment of pharmaceuticals. Regulatory Toxicology and Pharmacology 1997, 25:220-225.
7. Huber C., Bartha B., Harpaintner R., Schroder P. Metabolism of acetaminophen (paracetamol) in plants-two independent pathways result in the formation of a glutathione and a glucose conjugate. Environmental Science and Pollution Research 2009, 16(2):206-213.
8. Jones O.A.H., Voulvoulis N., Lester J.N. Human pharmaceuticals in the aquatic environment: a review. Environmental Technology 2001, 22:1383-1394.
9. Jones O.A.H., Voulvoulis N., Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research 2002, 36:5013-5022.
10. Jones O.A.H., Voulvoulis N., Lester J.N. Partitioning of selected pharmaceuticals compounds during activated sludge treatment. Archives of Environmental Contamination and Toxicology 2006, 50:297-305.
11. Jones O.A.H., Voulvoulis N., Lester J.N. The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilizing activated sludge treatment. Environmental Pollution 2007, 145:738-744.
12. Kadlec R.H. Deterministic and stochastic aspects of constructed wetland performance and design. Water Science and Technology 1997, 35(5):149-156.
13. Kasprzyk-Horderna B., Dinsdale R.M., Guwy A.J. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Research 2008, 42:3498-3518.
14. Lam M.W., Young C.J., Brain R.A., Johnson D.J., Hanson M.A., Wilson C.J., Richards S.M., Solomon K.R., Mabury S.A. Aquatic persistence of eight pharmaceuticals in a microcosm study. Environmental Toxicology and Chemistry 2004, 23:1431-1440.
15. Levenspiel O., Smith W.K. Notes on the diffusion type model for the longitudinal mixing of fluids in flow. Chemical Engineering Science 1957, 6:227-235.
16. Matamoros V., Bayona J.M., Garcia J. Behavior of selected pharmaceuticals in subsurface flow constructed wetlands: a pilot-scale study. Environmental Science and Technology 2005, 39:5449-5454.
17. Matamoros V., Bayona J.M. Elimination of pharmaceuticals and personal care products in subsurface flow constructed wetlands. Environmental Science and Technology 2006, 40:5811-5816.
18. Matamoros V., Arias C.A., Brix H., Bayona J.M. Removal of pharmaceuticals and personal care products (PPCPs) from urban wastewater in a pilot vertical subsurface-flow constructed wetland and a sand filter. Environmental Science and Technology 2007, 41:8171-8177.
19. Matamoros V., Puigagut J., Garci{dotless}a J., Bayona J.M. Behavior of selected priority organic pollutants in horizontal subsurface flow constructed wetlands: a preliminary screening. Chemosphere 2007, 69:1374-1380.
20. Matamoros V., Garci{dotless}a J., Bayona J.M. Organic micropollutant removal in full-scale surface flow constructed wetland fed with secondary effluent. Water Research 2008, 42:653-660.
21. Matamoros V., Arias C., Brix H., Bayona J.M. Preliminary screening of small-scale domestic wastewater treatment systems for removal of pharmaceutical and personal care products. Water Research 2009, 43:55-62.
22. Mitsch, W.J, Gosselink, J.G., 2000. 'Wetlands', third ed. John Wiley & Sons, Inc., New York.
23. Onesios K.M., Yu J.T., Bouwer E.J. Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review. Biodegradation 2009, 20:441-466.
24. Petrovic M., Gonzalez S., Barceló D. Analysis and removal of emerging contaminants in wastewater and drinking water. Trends in Analytical Chemistry 2003, 22:685-696.
25. Puigagut J., Salvadó H., García D., Granes F., García J. Effect of soluble and particulate organic compounds on microfauna the community in subsurface flow constructed wetlands. Water Research 2007, 29:280-286.
26. Richardson M.L., Bowron J.M. The fate of pharmaceutical chemicals in the environments. Pharmacy and Pharmacology 1985, 37:1-12.
27. Rousseau D.P.L., Vanrolleghem P.A., De Pauw N. Model-based design of horizontal subsurface flow constructed treatment wetlands: a review. Water Research 2004, 38:1484-1493.
28. Sheen L., Dillon J.F., Bateman D.N., Simpson K.J., Macdonald T.M. Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. QJM 2002, 95:609-619.
29. Shappell N.W., Billey L.O., Forbes D., Matheny T.A., Poach M.E., Reddy G.B., Hunt P.G. Estrogenic activity and steroid hormones in swine wastewater through a lagoon constructed-wetland system. Environmental Science and Technology 2007, 41:444-450.
30. Stuer-Lauridsen F., Birkved M., Hansen L.P., Holten L.H.C., Halling-Sørensen H.C. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 2000, 40:783-793.
31. Ternes A.T., Joss A., Siegrist H. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science and Technology 2004, 38:393A-398A.
32. Trovó, A.G., Santos Melo, S.A., Pupo Nogueira, R.F., 2008. Photodegradation of the pharmaceuticals amoxicillin, bezafibrate and paracetamol by the photo-Fenton process-application to sewage treatment plant effluent. Journal of Photochemistry and Photobiology A: Chemistry 198, 215-220.
33. Verlicchi P., Galletti A., Petrovic M., Barceló D. Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. Journal of Hydrology 2010, 389:416-428.
34. Yamamoto H., Nakamura Y., Moriguchi S., Nakamura Y., Honda Y., Tamura I., Hirata Y., Hayashi A., Sekizawa J. Persistence and partitioning of eight selected pharmaceuticals in the aquatic environment: laboratory photolysis, biodegradation, and sorption experiments. Water Research 2009, 43:351-362.
35. Yu-Chen Lin A., Debroux J.F., Cunningham J.A., Reinhard M. Comparison of rhodamine WT and bromide in the determination of hydraulic characteristics of constructed wetlands. Ecological Engineering 2003, 20(1):75-88.